A single-center, double-blind, randomized controlled trial for ultra-low-dose (selective photon shield) versus standard-dose protocol for computed tomography-guided microwave ablation of lung tumor

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032481

Enrollment

Unknown

Registered

2020-04-29

Start date

2020-05-01

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Control group:Standard-dose protocol

Experimental group:Ultra-low radiation dose protocol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old; 2. patients with pathologically proven stage I peripheral early non-small cell lung cancer (NSCLC) (tumor maximum diameter 3cm, who are treated with multiple points or multiple treatments, or combined with other treatment methods; 5. Patients with solitary recurrence of lung cancer after operation; 6. Patients with lung tumor progression or recurrence after peripheral NSCLC chemotherapy or molecular targeted drug treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with severe bleeding tendency, platelet 18S, prothrombin activity 3.

Design outcomes

Primary

Measure	Time frame
technical sucess rate;	—

Secondary

Measure	Time frame
therapeutic response;operation duration;image quality;incidence of complications;	—

Countries

China

Contacts

Public ContactJialin Shen

Renji Hospital Affiliated to Shanghai Jiaotong University

jialinshen123@163.com+86 15840174474

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026